• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Dr. Robert Justice Selected as the Director of the Division of Drug Oncology Products

Dr. Robert Justice has been selected as the Director of the Division of Drug Oncology Products, effective June 11, 2006. He brings a wealth of clinical, regulatory, and scientific experience to his new position.

Dr. Justice obtained his S.B. degree in Life Sciences from the Massachusetts Institute of Technology and received his medical degree from the School of Medicine, University of California at Davis. He also holds a Master's degree in Biotechnology from Johns Hopkins University. Dr. Justice did his internal medicine residency and medical oncology fellowship at the University of Hawaii and is board-certified in hematology and oncology; he has published numerous abstracts and papers in the field of medical oncology.

Following completion of his post-graduate training, Dr. Justice served as an Assistant Professor in the Division of Hematology/Oncology at the Texas Tech University Health Sciences Center in Amarillo, TX. He joined the FDA in 1985 and served as a medical officer in the Division of Oncology and Radiopharmaceutical Drug Products until 1989. He was briefly in private practice in Honolulu, HI before returning to FDA as a medical officer in the Division of Oncology and Pulmonary Drug Products; he subsequently served as a Medical Team Leader in that division and later as deputy division director and acting division director for the Division of Oncology Drug Products.

Dr. Justice worked as a Senior Clinical Scientist at Genentech from 2000 to 2002 on new therapies for cancer before rejoining FDA as director of the Division of Gastrointestinal and Coagulation Drug Products. He subsequently has served as deputy director of the Division of Biologic Oncology Products and then as acting director for DDOP for several months, where he has done an outstanding job.